SARSYS (SARS) Q2 2025 earnings summary

Executive summary

• Revenue grew 14% year-over-year in Q2 2025, reaching 9.5 MSEK, with improved operating loss of -3.2 MSEK compared to -4.9 MSEK last year.

• Order intake in Q2 was 8.2 MSEK, up 71% year-over-year, signaling early signs of market recovery.

• The company continued its efficiency program, focusing on cost discipline and scalability.

Financial highlights

• Net sales for H1 2025 were 17.9 MSEK, up from 16.2 MSEK year-over-year.

• Operating result for H1 2025 was -8.7 MSEK, down from -7.9 MSEK, impacted by inventory changes and higher external costs.

• Net result for H1 2025 was -9.4 MSEK, with EPS at -0.27 SEK, compared to -8.5 MSEK and -0.60 SEK last year.

• Gross margin declined to 52% from 55% year-over-year.

• Cash and cash equivalents at June 30 were 4.8 MSEK, up from 4.0 MSEK last year.

Outlook and guidance

• Market conditions remain challenging but show early improvement signs.

• Ongoing efficiency initiatives are expected to support further development in coming quarters.

• No Q3 interim report will be published; next report is the year-end statement in February 2026.